1. Introduction {#sec1}
===============

Liver transplantation (LT) is a life-saving therapy for patients with liver cancer and end-stage liver disease \[[@B1]\]. In the United States in the year 2015, 7127 LTs were performed \[[@B2]\]. The countries with the second and third highest rates of LT are China (\>3500 LTs in 2005) and Brazil (1756 in 2015) \[[@B3], [@B4]\]. While the LT procedure has been standardized to a considerable extent, the management of postoperative complications remains a major challenge. In particular, LT patients are at elevated risk of developing sepsis, a systemic inflammation and immune system dysregulation \[[@B5]--[@B7]\]. Without proper and timely treatment, LT-related sepsis can result in longer hospital stays and even death. Identifying the risk factors of LT-related sepsis would facilitate its earlier recognition and management.

Many factors have been proposed as potential predictors of LT-related sepsis, including exhaled nitric oxide, aerobic capacity, plasma amino acid profile, and muscle wasting \[[@B8]--[@B10]\]. However, most of these risk factors concern only the postoperative period, and the value of these reports has been limited by the lack of a clear definition of postoperative sepsis.

In 2016, the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) was released by the American Medical Association \[[@B11]\]. Sepsis-3 is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection, determined as a SOFA (sequential sepsis-related organ failure assessment) score ≥ 2 points \[[@B11]\]. Previous definitions of sepsis were based largely on scores related to systemic inflammatory response syndrome (SIRS), but the newly released Sepsis-3 guidelines emphasize the importance of the nonhomeostatic host response to infection and the SOFA score \[[@B12], [@B13]\]. Since its publication, the Sepsis-3 report has been cited 1673 times (as of October 6, 2017). Research results that utilize the Sepsis-3 criteria have a great value in clinical practice.

The present retrospective study applied the Sepsis-3 criteria to investigate the pre-, peri-, and postoperative risk factors of LT-related sepsis in 126 patients who underwent orthotopic liver transplantation (OLT).

2. Patients and Methods {#sec2}
=======================

2.1. Study Population {#sec2.1}
---------------------

The Research Ethics Committee at the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, reviewed and approved this retrospective study (\[2015\]2-190). After searching the medical records of the patients admitted from February 2012 to March 2015 at the Third Affiliated Hospital of Sun Yat-sen University, 140 consecutive OLT cases were obtained. Patients with any of the following were excluded from this analysis: aged \<18 or \>70 years (*n* = 4), repeat OLT (*n* = 2), combined liver and kidney transplantation (*n* = 2), cardiopulmonary bypass during OLT (*n* = 1), primary graft nonfunction (*n* = 1), or lost to follow-up (*n* = 4). Finally, 126 OLT cases were included and allotted to either a sepsis-positive group or sepsis-negative group, in which sepsis was diagnosed based on the newly released Sepsis-3 criteria ([Figure 1](#fig1){ref-type="fig"}).

Eleven patients with a SOFA score ≥ 2 points were identified as sepsis-positive \[[@B11]\]. The SOFA comprises scores relevant to the following organ systems and graded from 0 to 4 according to the degree of dysfunction or failure (see Vincent et al. 1998 for details) \[[@B14]\]: respiration (PaO~2~/FiO~2~ ratio), coagulation (platelets), the liver (bilirubin), cardiovascular (mean artery pressure), the central nervous system (Glasgow coma score), and renal (creatinine and urine output).

2.2. Data Collection {#sec2.2}
--------------------

The following data were collected: gender; recipient age; body mass index (BMI); primary disease for OLT; history of previous surgeries, diabetes, and hypertension; hospitalization expenses; preoperative Child-Pugh class and model for end-stage liver disease (MELD) score; and preoperative infection. Preoperative laboratory tests included white blood cell count (WBC); serum creatinine (SCr); blood urea nitrogen (BUN); prothrombin time (PT); activated partial thromboplastin time (APTT); blood glucose; and serum levels of sodium, potassium, and calcium.

Perioperative data included the following: hepatic cold ischemia time; durations of anesthesia, OLT, and anhepatic phase; hemorrhage and blood transfusion volumes (red blood cell, plasma, and fresh frozen plasma); intraoperative fluid or albumin infusions; hypokalemia and acidosis; and usage of ulinastatin (Guangdong Techpool Bio-pharma, Guangzhou City, Guangdong Province, China).

Postoperative observations were duration of mechanical ventilation; time in intensive care unit (ICU); infection; and usage of alprostadil (Beijing Tide Pharmaceutical, Beijing, China), terlipressin (Hybio Pharmaceutical, Shenzhen City, Guangdong Province, China), and recombinant human interleukin 11 (rhIL-11; Qilu Pharmaceutical, Jinan City, Shandong Province, China).

2.3. Statistical Analysis {#sec2.3}
-------------------------

Continuous and categorical variable data are presented as mean ± standard deviation or number (percentage). The normality of the measurement data was tested using the one-sample Kolmogorov-Smirnov test. Abnormally distributed measurement data are shown as median and range. A 2-tailed independent sample *t*-test was used to compare normally distributed measurement data, and the Wilcoxon rank sum test was used to compare abnormally distributed measurement data. Pearson\'s chi-squared test was applied to analyze enumeration data (except for survival rate). Variables that were significantly different between the sepsis-positive and sepsis-negative groups were subjected to logistic regression for univariate and multivariate analyses. Significance was set at *P* \< 0.05. All statistical analyses were performed using SPSS 23 (IBM, Chicago, IL) software.

3. Results {#sec3}
==========

3.1. Incidence of Sepsis after OLT {#sec3.1}
----------------------------------

Based on the Sepsis-3 criteria, 85 of the 126 OLT patients were diagnosed as sepsis. Detailed information with regard to the diagnosis of sepsis is listed in Supplemental [Table 1](#supplementary-material-1){ref-type="supplementary-material"} and Supplemental Excel [File 1](#supplementary-material-1){ref-type="supplementary-material"}. Eleven of those sepsis patients developed septic shock. The major pathogens were Gram-negative bacteria and fungi ([Table 1](#tab1){ref-type="table"}).

3.2. Prognosis of Patients with or without OLT-Related Sepsis {#sec3.2}
-------------------------------------------------------------

Compared with the sepsis-negative group ([Table 2](#tab2){ref-type="table"}), a significantly higher percentage of the patients in the sepsis-positive group underwent dialysis after OLT (49.4% cf. 4.8%, *P* \< 0.001), and the duration of mechanical ventilation was longer (1.5 d cf. 1 d, *P* = 0.022). Patients with sepsis had significantly worse survival rate than patients without sepsis (*P* = 0.0215) ([Figure 2](#fig2){ref-type="fig"}). The sepsis-positive patients also had higher hospitalization costs (0.41 million cf. 0.30 million, Chinese RMB; *P* \< 0.001) ([Table 2](#tab2){ref-type="table"}).

3.3. Preoperative Data Screening {#sec3.3}
--------------------------------

The sepsis-positive and sepsis-negative groups were significantly different with regard to the following (Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}): gender ratio (*P* = 0.044), Child-Pugh grade (*P* = 0.014), MELD score (*P* = 0.049), and serum calcium concentration (*P* = 0.011). All of the 16 women in this study suffered sepsis. Compared with the sepsis-negative group, a significantly larger percentage of patients in the sepsis-positive group was Child-Pugh grade C, had a MELD score \< 11, and experienced hypercalcemia.

3.4. Perioperative Data Screening {#sec3.4}
---------------------------------

Compared with the sepsis-negative patients, during the OLT, the sepsis-positive group had significantly higher volumes of red blood cell infusion (*P* = 0.010) and fluid infusion (*P* = 0.049) ([Table 5](#tab5){ref-type="table"}). The percentage of patients who evidenced perioperative acidosis was also significantly higher in the sepsis-positive patients (*P* = 0.017).

3.5. Postoperative Data Screening {#sec3.5}
---------------------------------

None of the postoperative observations (albumin infusion volume, the incidence of pneumonia and intestinal infection, serum potassium level, and blood glucose level) were significantly different between the sepsis-positive and sepsis-negative groups (*P* \> 0.05, see [Table 6](#tab6){ref-type="table"}).

3.6. Risk Factors for Sepsis after OLT {#sec3.6}
--------------------------------------

During the initial data screening, 7 pre- and perioperative characteristics were identified as potential risk factors for sepsis: gender ratio; preoperative Child-Pugh stage, MELD score, and blood calcium level; and peri-operative red blood cell infusion and total fluid infusion, and acidosis. Since the 16 women in this study all experienced sepsis, the gender ratio was excluded from the subsequent logistic regression. The patients were stratified based on perioperative red blood cell infusion (≤2250 ml and \>2250 ml).

The univariate analysis showed that the following preoperative features were risk factors for sepsis after OLT ([Table 7](#tab7){ref-type="table"}): Child-Pugh grade C (*P* = 0.006) and hypercalcemia (*P* = 0.014). In addition, the univariate analysis showed that the following perioperative features were risk factors for sepsis after OLT: red blood cell transfusion \> 2250 ml (*P* = 0.033) and acidosis (*P* = 0.029).

Results of the multivariate analysis indicated that the following were independent risk factors of sepsis after OLT ([Table 8](#tab8){ref-type="table"}): preoperative Child-Pugh grade C (OR 10.43; 95% CI 2.081--52.292; *P* = 0.004), preoperative hypercalcemia (OR 6.372; 95% CI 1.693--23.98; *P* = 0.006), and perioperative acidosis (OR 6.364; 95% CI 1.196--33.869; *P* = 0.030).

4. Discussion {#sec4}
=============

Sepsis is a common and serious postoperative problem in OLT patients. In this study, 67% of the patients developed sepsis after OLT, and the development of sepsis was associated with higher rates of dialysis, prolonged duration of mechanical ventilation, greater economic burden, and worse overall survival. Early recognition of sepsis would help enable timely treatment and benefit the patients physically and economically. Our results indicated that the following factors may predict sepsis after OLT: preoperative Child-Pugh class C, preoperative hypercalcemia, and perioperative acidosis. Thus, both pre- and perioperative management strategies are essential for controlling postoperative sepsis in OLT patients.

Of particular note is that, in the current study, the newly published Sepsis-3 criteria were applied for the diagnosis of postoperative sepsis and categorizing patients for the analysis. The Sepsis-3 criteria were developed with reference to the latest understanding of the pathobiology, management, and epidemiology of sepsis \[[@B11]\] and have been accepted as a more specific and sensitive definition when compared with previous sepsis definitions \[[@B14], [@B15]\]. Since Sepsis-3 utilizes the SOFA score but does not consider SIRS, a small portion of the previous sepsis-positive patients may be considered sepsis-negative, and some of the previous sepsis-negative may be considered sepsis-positive \[[@B16], [@B17]\]. Thus, the risk factors of OLT-related sepsis that were identified by previous sepsis definitions require reevaluation under the new Sepsis-3 definition.

Nemes et al. conducted a retrospective study with 199 consecutive OLT patients and found that the recipient Child-Pugh grade could be used as an independent risk factor for predicting sepsis \[[@B18]\]. While those researchers used a previous definition of sepsis, in the present study, we confirmed that the preoperative Child-Pugh grade was an independent risk factor for sepsis under the Sepsis-3 definition. In Yoshizumi et al., another study conducted under the previous sepsis definition, the preoperative MELD score (\>15) and the duration of the OLT (\>14 h) were identified as independent risk factors for postoperative bacterial sepsis \[[@B19]\]. However, in our current study which grouped patients based on Sepsis-3, the preoperative MELD score and the duration of OLT had no statistical value for predicting sepsis.

This is the first study to identify hypercalcemia as an independent risk factor for sepsis after OLT. In general, critical surgical illness is accompanied by low total calcium concentration, low ionized calcium concentration, or both \[[@B20]\]. However, Forster et al. reviewed 100 patients in the surgical ICU and found that 85 of them developed hypercalcemia after surgery \[[@B20]\]. Interestingly, in the same study, they reported that patients who developed hypercalcemia had significantly higher rates of shock, bacteremia, renal failure, and significantly more transfusions, antibiotics, dialysis, and parenteral nutrition usage, when compared with the patients without hypercalcemia \[[@B20]\]. These results suggest that preoperative hypercalcemia may be an important risk factor for severe illness, including sepsis, in the surgical ICU. Sugimoto et al. reported that sepsis was associated with higher levels of circulatory proinflammatory cytokines (particularly interleukin-6) and bone resorption, by promoting osteoclast activity and inhibiting osteoblast activity \[[@B21]\]. These features subsequently led to hypercalcemia. In the current study, preoperative hypercalcemia was identified as a predictor of post-OLT sepsis. Thus, timely monitoring and maintaining the serum calcium level would help improve the outcome of OLT.

The blood lactic acid level has increasingly been considered as an independent risk factor of sepsis severity \[[@B22], [@B23]\]. Tissue hypoxia and epinephrine-induced stimulation of aerobic glycolysis have been proposed as the main mechanisms that contribute to lactic acid accumulation during sepsis \[[@B20]\]. Severe lactic acidosis (blood pH \< 7.2) is closely associated with high mortality rates in patients with sepsis \[[@B24]\]. Lee et al. reported that the lactate level 6 hours after early quantitative resuscitation is a strong predictor of a 28-day mortality in patients with sepsis or septic shock \[[@B25]\]. Marty et al. reported that lactate clearance during the first 24 hours could be used to predict a 28-day mortality rate in septic patients hospitalized in the surgical ICU \[[@B26]\]. In the present study, the perioperative, but not postoperative, blood lactic acid level showed statistical value for predicting sepsis after OLT.

The goal of the present study was to investigate the potential risk factors for OLT-related sepsis under the newly released Sepsis-3 criteria \[[@B11]\]. This study did not attempt to compare the differences between Sepsis-3 and the previous sepsis definitions.

While statistically valid risk factors were identified, this study has limitations. Most of the livers were donated from cardiac death donors. Additional work will be needed to verify the current findings with a larger sample scale and well-recorded follow-up.

5. Conclusions {#sec5}
==============

This is the first report that identifies risk factors for OLT-related sepsis based on the newly released Sepsis-3 criteria. This study found that preoperative Child-Pugh grade C, preoperative hypercalcemia, and perioperative acidosis were independent risk factors for sepsis after OLT. Thus, for patients scheduled for OLT, recognizing the importance of preoperative Child-Pugh grade C, preoperative hypercalcemia, and perioperative acidosis should help to plan timely management and improve the prognosis of OLT.
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###### 

Supplementary Table 1: diagnosis of the 85 sepsis patients according to Sepsis-3 criteria.

###### 

Click here for additional data file.
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###### 

The major pathogens for sepsis after orthotopic liver transplantation (OLT).

  Pathogens                           Percentage (%)
  ----------------------------------- ----------------
  Gram-negative bacteria              29
   *Acinetobacter baumannii*          10
   *Klebsiella pneumoniae*            5
   *Pseudomonas aeruginosa*           3
   *Enterobacter cloacae*             2
   *Stenotrophomonas maltophilia*     6
   *Flavobacterium meningosepticum*   2
   *Ralstonia pickettii*              1
  Fungi                               14
   *Candida albicans*                 5
   *Candida glabrata*                 3
   *Candida guilliermondii*           2
   *Trichosporon asahii Akagi*        1
   Others                             3

###### 

Prognosis of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (reported as *n* (%), unless otherwise noted).

                                        Sepsis-negative     Sepsis-positive     *P*
  ------------------------------------- ------------------- ------------------- ---------
  Subjects, *n*                         41                  85                  ---
  Dialysis                              2 (4.8)             42 (49.4)           \<0.001
  Reintubation/tracheostomy             3 (7.3)             16 (18.8)           0.334
  Fiber bronchoscope suction            8 (19.5)            10 (11.7)           0.543
  Medicines after OLT                                                           
   Alprostadil                          19 (46.3)           21 (24.7)           0.052
   Terlipressin                         6 (14.6)            10 (11.8)           0.880
  RhIL-11^a^                            17 (41.5)           19 (22.4)           0.071
  Duration of ICU^b^ stay, d            3 (2--5)            3.5 (2--10)         0.072
  Mechanical ventilation, d             1 (1--1)            1.5 (1--3)          0.022
  Returning to ICU                      3 (7.3)             14 (16.5)           0.438
  Hospitalization after OLT, d          35 (28--48)         44 (38--63)         0.066
  Hospitalization costs, 10^6^ RMB^c^   0.30 (0.24--0.34)   0.41 (0.34--0.63)   \<0.001

^a^RhIL-11: recombinant human interleukin 11; ^b^ICU: intensive care unit; ^c^RMB: Chinese renminbi.

###### 

Preoperative clinical characteristics of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (normally distributed data) (reported as *n* (%) unless otherwise noted).

                            Sepsis-negative   Sepsis-positive   *P*
  ------------------------- ----------------- ----------------- -------
  Age, y                    44.44 ± 8.63      49.08 ± 10.92     0.067
  Male/female               41/0              69/16             0.044
  Portal hypertension       21 (51.2)         46 (54.1)         0.555
  Hypertension              0                 8 (9.4)           0.260
  Serum albumin, g/l        32.69 ± 5.62      35.54 ± 6.08      0.155
  Smoking                   6 (14.6)          13 (15.3)         1.000
  Drinking                  8 (19.5)          13 (15.3)         0.886
  Diabetes                  10 (24.4)         18 (21.2)         0.813
  Etiology                                                      
   Liver cirrhosis          14 (34.1)         27 (31.8)         0.099
   Severe hepatitis         6 (14.6)          19 (22.4)         
   Hepatic carcinoma        17 (41.5)         17 (20)           
   Others                   3 (7.3)           21 (24.7)         
  Child-Pugh grade                                              
   A                        14 (34.1)         8 (9.4)           0.014
   B                        11 (26.8)         21 (24.7)         
   C                        16 (39.0)         56 (65.9)         
  MELD^a^ score                                                 
   \<11                     9 (22.0)          35 (41.2)         0.049
   11--18                   19 (46.3)         24 (28.2)         
   19--24                   5 (12.2)          21 (24.7)         
   ≥25                      8 (19.5)          5 (5.9)           
  Serum potassium                                               
   Normal                   35 (85.4)         61 (71.8)         0.372
   Hypokalemia              5 (12.2)          21 (24.7)         
   Hyperkalemia             2 (4.8)           3 (3.5)           
  Serum sodium                                                  
   Normal                   25 (60.9)         56 (65.9)         0.694
   Hyponatremia             16 (39.0)         29 (34.1)         
  Serum calcium                                                 
   Normal                   33 (80.5)         43 (50.6)         0.011
   Hypercalcemia            8 (19.5)          42 (49.4)         
  Blood glucose                                                 
   Normal                   22 (53.7)         54 (63.5)         0.461
   Hypoglycemia             11 (26.8)         13 (15.3)         
   Hyperglycemia            8 (19.5)          18 (21.1)         
  Pneumonia                 17 (41.5)         27 (31.8)         0.372
  Biliary tract infection   6 (14.6)          6 (7.1)           0.491
  Other infection           10 (24.4)         13 (15.3)         0.578

^a^MELD: model for end-stage liver disease.

###### 

Preoperative measurements of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (abnormally distributed data).

                                             Sepsis-negative         Sepsis-positive         *P*
  ------------------------------------------ ----------------------- ----------------------- -------
  Subjects, *n*                              41                      85                      ---
  White blood cell count, ×10^9^/l           10.13 (3.45--15.43)     5.17 (2.84--10.37)      0.061
  Prothrombin time, s                        21.80 (16.70--33.00)    26.80 (15.90--34.70)    0.754
  Activated partial thromboplastin time, s   71.00 (46.00--76.00)    59.00 (41.00--71.40)    0.236
  Serum creatinine, *μ*mol/l                 80.00 (66.00--168.50)   84.00 (66.50--105.50)   0.406
  Blood urea nitrogen, mmol/l                13.60 (4.53--31.56)     6.20 (3.88--12.61)      0.059

###### 

Perioperative characteristics of patients with or without orthotopic liver transplantation- (OLT-) related sepsis.

                                       Sepsis-negative        Sepsis-positive        *P*
  ------------------------------------ ---------------------- ---------------------- -------
  Cold ischemia, h                     6.00 (6.00--8.00)      6.00 (5.25--6.75)      0.217
  OLT, h                               6.92 (6.11--8.42)      7.00 (6.07--8.33)      0.829
  Anhepatic phase, min                 52.00 (46.00--60.50)   52.00 (47.00--65.00)   0.728
  Ulinastatin, million U               0.60 (0.53--0.65)      0.60 (0.3--0.63)       0.082
  Albumin infusion, ml                 200 (150--300)         250 (150--300)         0.365
  Red blood cell transfusion, ml       1675 (750--2800)       2800 (1500--4400)      0.010
  Plasma transfusion, l                3.00 (2.35--4.00)      3.40 (2.30--5.50)      0.286
  Fresh frozen plasma transfusion, U   39.00 (22.50--47.50)   40.00 (30.00--50.00)   0.485
  Fluid infusion, ml                   6375 (5690--7300)      7700 (6253--10,120)    0.049
  Bleeding volume, ml                  2500 (1000--3450)      3000 (1800--6000)      0.113
  Urine volume, ml                     1600 (1300--2125)      1350 (763--2000)       0.081
  Hypokalemia, *n* (%)                 5 (12.2)               26 (30.6)              0.068
  Acidosis, *n* (%)                    3 (7.3)                27 (31.8)              0.017

###### 

Postoperative clinical characteristics of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (reported as *n* (%), unless otherwise noted).

                         Sepsis-negative    Sepsis-positive    *P*
  ---------------------- ------------------ ------------------ -------
  Subjects, *n*          41                 85                 ---
  Albumin infusion, ml   1700 (600--2450)   2100 (950--2900)   0.357
  Pneumonia              29 (70.7)          53 (62.4)          0.720
  Intestinal infection   13 (31.7)          18 (21.2)          0.328
  Serum potassium                                              
   Normal                29 (70.7)          37 (43.5)          0.060
   Hypokalemia           11 (26.8)          46 (54.1)          
   Hyperkalemia          2 (4.8)            2 (2.3)            
  Blood glucose                                                
   Normal                8 (19.5)           27 (31.8)          0.231
   Abnormal^a^           33 (80.5)          58 (68.2)          

^a^All of the abnormal blood glucose patients were in hyperglycemia, except one patient was in hypoglycemia in the sepsis-positive group.

###### 

Univariate logistic analysis for the incidence of sepsis after orthotopic liver transplantation (OLT) (reported as *n* (%), unless otherwise noted).

                                 B        SE      Wals    Sig.    Exp (B) 95% CI
  ------------------------------ -------- ------- ------- ------- -----------------------
  Preoperative                                                    
   Child-Pugh grade                                               
    A                            ---      ---     7.734   0.021   ---
    B                            1.207    0.729   2.743   0.098   3.343 (0.802--13.942)
    C                            1.841    0.663   7.705   0.006   6.3 (1.718--23.108)
   MELD^a^ score                                                  
    \<11                         ---      ---     7.353   0.061   ---
    11--18                       −1.076   0.602   3.198   0.074   0.341 (0.105--1.109)
    19--24                       0.167    0.789   0.045   0.832   1.182 (0.252--5.547)
    ≥25                          1.81     0.863   4.395   0.116   0.164 (0.103--1.889)
   Hypercalcemia                 1.397    0.568   6.043   0.014   4.044 (1.327--12.323)
  Perioperative                                                   
   RBC^b^ infusion (\>2250 ml)   1.112    0.521   4.558   0.033   3.04 (1.095--8.436)
   Fluid infusion                1.647    1.107   3.014   0.812   5.689 (1.283--35.687)
   Acidosis                      1.735    0.793   4.789   0.029   5.667 (1.18--26.793)

^a^MELD: model for end-stage liver disease; ^b^RBC: red blood cell.

###### 

Multivariate logistic analysis for the incidence of sepsis after orthotopic liver transplantation (OLT).

                                          B       SE      Wals    Sig.                    Exp (B) 95% CI
  ------------------------------- ------- ------- ------- ------- ----------------------- -----------------------
  Preoperative Child-Pugh grade                                                           
   A                              ---     ---     8.152   0.017   ---                     
   B                              1.652   0.891   3.441   0.064   5.22 (0.911--29.915)    
   C                              2.345   0.823   8.126   0.004   10.43 (2.081--52.292)   
  Hypercalcemia                           1.852   0.676   7.5     0.006                   6.372 (1.693--23.98)
  Perioperative acidosis                  1.851   0.853   4.706   0.03                    6.364 (1.196--33.869)
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